{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T09:24:23Z","timestamp":1781774663305,"version":"3.54.5"},"reference-count":0,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2002,1,5]],"date-time":"2002-01-05T00:00:00Z","timestamp":1010188800000},"content-version":"vor","delay-in-days":796,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Scand J Immunol"],"published-print":{"date-parts":[[1999,11]]},"abstract":"<jats:p>Leprosy patients during the natural course of the disease may develop reactional episodes, namely reversal reaction (RR) and erythema nodosum leprosum (ENL). Immunological events described as occurring during RR indicate up\u2010regulation of the immune response, whereas in ENL the events are not fully understood. The aim of this study was to analyse the <jats:italic>in vivo<\/jats:italic> pattern of cytokine gene expression in the reactional states of leprosy. Peripheral blood mononuclear cells (PBMC, <jats:italic>n<\/jats:italic>\u2003=\u200314) and tissue samples (<jats:italic>n<\/jats:italic>\u2003=\u200317) obtained from patients with ENL and RR were obtained and assayed by RT\u2010PCR. PBMC obtained from unreactional patients (<jats:italic>n<\/jats:italic>\u2003=\u200315) and normal individuals (<jats:italic>n<\/jats:italic>\u2003=\u20035) were also assessed. Expression of interferon (IFN)\u03b3, granulocyte\u2010macrophage colony stimulating factor (GM\u2010CSF), interleukin (IL)\u20102Rp55, perforin and IL\u20101\u03b2 mRNA in PBMC were detected mostly in ENL\/RR patients, but not in unreactional patients. Likewise, cytokines such as IL\u20106, IL\u20108, tumour necrosis factor (TNF)\u03b1 and TNF\u03b2 were also present in reactional and tuberculoid patients as opposed to lepromatous leprosy (BL\/LL). Interestingly, the majority of ENL\/RR patients showed messages for IL\u20106, IL\u201010, IL\u201012 and TNF\u03b1 in the skin. IFN\u03b3 was detected in 84.6% (ENL) and 100% (RR) of the patients, whereas IL\u20104 was detected only in few individuals (38.5 and 25%, respectively). Although mRNA expression and protein levels may be different, the data reported in this study suggest a cytokine mRNA profile that seems to be indistinguishable for RR and ENL. In addition, it shows up\u2010regulation of immuno\u2010inflammatory cytokines in the blood and tissue of the same patient examined before and during reaction. Furthermore, it is suggested that this pattern of response results from an immunological reactivation that might lead to an acute inflammatory response in both reactional episodes.<\/jats:p>","DOI":"10.1046\/j.1365-3083.1999.00622.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T20:12:59Z","timestamp":1047499979000},"page":"541-549","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":71,"title":["Cytokine mRNA Expression in Leprosy: a Possible Role for Interferon\u2010\u03b3 and Interleukin\u201012 in Reactions (RR and ENL)"],"prefix":"10.1111","volume":"50","author":[{"family":"Moraes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Sarno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Saraiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Nery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Sampaio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2002,1,5]]},"container-title":["Scandinavian Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-3083.1999.00622.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-3083.1999.00622.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T20:27:50Z","timestamp":1698524870000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-3083.1999.00622.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,11]]},"references-count":0,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1999,11]]}},"alternative-id":["10.1046\/j.1365-3083.1999.00622.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-3083.1999.00622.x","archive":["Portico"],"relation":{},"ISSN":["0300-9475","1365-3083"],"issn-type":[{"value":"0300-9475","type":"print"},{"value":"1365-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,11]]},"assertion":[{"value":"2002-01-05","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}